Knee pain. Other chronic pain
Conditions
Interventions
Intervention 1: Intervention group: In these individuals, the patients autologous blood is used, which is added to the company's (Zana Foundational Medicine) Protokine kits, which contain platelets,
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients between the ages of 40 and 70 Suffering from knee osteoarthritis grade 2 and 3 American Society of Anesthesiologists (ASA) class 1 and 2 classifications
Exclusion criteria
Exclusion criteria: Patient's unwillingness to participate in the study Allergy to medications taken Cardiovascular disease and blood clotting disorders Joint infections immune disorder Rheumatic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Patients are followed up at baseline (before the start of the study), 1, 4, and 12 weeks after the injection. Method of measurement: The Numeric Rating Scale (NRS) are used to examine the data. | — |
Secondary
| Measure | Time frame |
|---|---|
| Performance limitation. Timepoint: Patients are followed up at baseline (before the start of the study), 1, 4, and 12 weeks after the injection. Method of measurement: The WOMAC criterion is used. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hossein Majedi Ardakani
Tehran University of Medical Sciences
Outcome results
None listed